REPORT OF UK BIOMATERIALS MEETING, IMPERIAL COLLEGE (HAMMERSMITH HOSPITAL), 17 NOVEMBER 1999

The full day meeting consisted of a morning session considering "Clinical Views on Biomaterials" followed by an informal afternoon networking opportunity.

The first presentation discussed the current status of biomaterial research in orthopaedic surgery (McCarthy, IC). Consideration was given to the current thinking relating to the need for approximately 40% revisions of hip/shoulder (total numbers 80,000 in UK) and knee (40,000 in UK) replacements.  Wear particle debris was demonstrated for alloy, polymer and ceramic materials as was the more recent concept of nitrogen oxide (NO) radical formation leading to inflammatory activity (at the bone/cement interface) and consequent failure of the replacement function. New metal/metal, ceramic/ceramic and isoelastic materials were not believed to be sufficiently promising. However porous surfaces/coatings (e.g. hydroxyapatite) were favoured, even though there was acknowledgement of concerns as to the likely long-term success of some such material in certain applications. A general overview of the recent Brite-EuRam intervertebral spacer project was presented, although there was a feeling put forward that poor nutrition of the natural disc (which leads to its failure) may also affect any implanted material. The requirement for replacement cartilage materials (beyond autologous seeding of chondrocytes to polyester/graphite) and new internal fixation glues/devices completed the presentation.

The second presentation considering "Contact Activation of Humeral and Cellular Blood Components (Asimakopoulos, IC), whilst interesting for the purpose of a cross-sector "teach-in", only really presented a text book overview of the issues.

The third presentation on "Maxillofacial Materials” (Fisher, Nottingham) highlighted the challenges facing the need for reconstruction of approximately 60% of the 500,000 (1997) facial injury/congenital defect cases in the UK. The difficulties in overcoming the variation in bone and soft tissue formation, stress/load bearing tissues, and facial contours were presented through interesting clinical cases. The lack of total resorption of some current materials (e.g. polylactic acid, PLA) and particulate migration of others (e.g. polyethylene, PE) was demonstrated. The concept of new materials with varying properties depending on application (e.g. PE-HA and caprolactam) was discussed.

Last, but by no means least, was the dual presentation of Polak and Hench (IC) entitled "Overview of the Current Status of Tissue Engineering". Although not really achieving the title, the concept of regeneration of engineered or bioactive materials (rather than current tissue replacement and past tissue removal approaches) was discussed through the example of a sol-gel (microporous) Bioglass. This material was shown to support cell growth, osteocalcin synthesis, bone nodule formation and collagen matrix deposition. Combined with micromechanical stimuli, simple seeded scaffolds were shown to lead to differentiated cells, although the need for much greater insight into extracellular matrix deposition with biomechanical properties was acknowledged.

The informal network session saw presentation of a report from the recent EU MATMED meeting and a short presentation from the UK EPSRC manager as to the potential role for UK Biomaterial participants in these projects/programmes.

Despite some interesting technical presentations, there must remain reservations as to the network's real long-term success without some form of re-assessment of its identity/purpose. Whilst possibly a one-off with regard to the topics chosen, the network was not particularly well attended either by academics or industrialists, thereby showing signs of its initial impetus stalling. The very low number of industrial participants in attendance created few networking opportunities and little industrial focus and the meeting broke early. This was despite a reported increase in interest in the network itself. Nonetheless, its future is in its own hands and that is always a good place to have it.

 

Dr J BRAYBROOK

 

 

 

All text and representations on this site © L P M Lloyd-Evans & BioBridge 2000-2005
mlloydevans@biobridge.co.uk.
Designed and managed by BioPortfolio Ltd on behalf of  L P M Lloyd-Evans & BioBridge Associates.

The foundation and maintenance of this site was made possible by EC funding in project BRRT-CT97-5008 1997-2000